Global Tumor Ablation Market 2015 - 2019; New Report Launched

Market outlook of the global tumor ablation market

Tumor ablation is a minimally invasive, image-guided treatment procedure that is used to destroy cancer cells in the chest, lung, and liver. Recent advances in semiconductor technology and modifications to the design of medical laser systems such as MRI or ultrasound are responsible for this markets healthy growth rate of more than 15% during the forecast period.

Geographically, the EMEA region is expected to account for the highest market share during the forecast period. The growing prevalence of cancer in countries such as Denmark, Belgium, France, and Norway is responsible for this regions high market share of close to 37% by 2019.

Segmentation by ablation technology and analysis of the tumor ablation market

• Radiofrequency
• Ultrasound
• Cryotherapy
• Microwave

In this market research report, Technavio analysts estimate the radiofrequency segment to account for approximately 13% of the total market share by 2019. Radiofrequency is very specific for treating target tissues without causing significant damage to surrounding healthy cells. The high efficacy rate of this procedure is expected to bolster its growth during the forecast period.

Cancer-type segmentation of the tumor ablation market

• Liver
• Breast
• Prostate
• Gynecological
• Lung
• ENT

The analyst has estimated the liver cancer segment to account for the highest market share during the forecast period. Liver cancer is more common in men than in women and is characterized by uncontrolled cell division in the liver. High incidence of primary liver cancer and bile duct cancer among the populace will result in this segments high market dominion during the forecast period.

Competitive landscape and key vendors

This market offers ample growth opportunities to vendors during the forecast period and is characterized by the presence of numerous local and multinational vendors. While the international players are continually increasing their footprint in the market through product innovations, local vendors adopt collaborations to stay competitive in the market.

Leading vendors in this market are-

• AngioDynamics
• Boston Scientific
• Ethicon
• Medtronic

Other prominent vendors are Alpinion Medical System, BSD Medical, Conmed, C2 Therapeutics, CSA Medical, C.R. Bard, Chongqing Haifu Medical Technology, Esaote, EDAP TMS, Galil Medical, InSightec, Misonix, Mermaid Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Plasma Surgical, Profound Medical, Philips Healthcare, Smith & Nephews, Sonacare Medical, Shenzhen Huikang Medical Apparatus, Terumo Medical, Total Vein Systems, Theraclion, and Vivant Medical.

Key questions answered in the report include

• What will the market size and the growth rate be in 2019
• What are the key factors driving the global tumor ablation market
• What are the key market trends impacting the growth of the global tumor ablation market
• What are the challenges to market growth
• Who are the key vendors in the global tumor ablation market
• What are the market opportunities and threats faced by the vendors in the global tumor ablation market
• Trending factors influencing the market shares of the EMEA, Americas, and APAC
• What are the key outcomes of the five forces analysis of the global tumor ablation market

Spanning over 70 pages  and 35 Exhibit “Global Tumor Ablation Market 2015 - 2019” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market Overview, Market Landscape, Cancer statistics, Pipeline analysis, Market segmentation by ablation technology, Market segmentation by cancer types, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Find more information Visit at: http://mrr.cm/orN

Find all Healthcare report at : http://www.marketresearchreports.com/healthcare